<DOC>
	<DOCNO>NCT00789685</DOCNO>
	<brief_summary>The purpose study assess safety , tolerability preliminary efficacy FP-1201 ( Interferon Beta ) patient Acute Lung Injury ( ALI ) Acute Respiratory Distress Syndrome ( ARDS ) .</brief_summary>
	<brief_title>Safety , Tolerability Preliminary Efficacy FP-1201 ALI ARDS . Phase I/II</brief_title>
	<detailed_description>This phase I/II open-label study ass safety , tolerability preliminary efficacy FP-1201 ( IFN β-1a ) treatment patient ALI ARDS . The primary objective study evaluate safety tolerability FP-1201 patient ALI/ARDS ass safety , tolerability preliminary efficacy optimum tolerate dose ( OTD ) patient likely derive clinical benefit . The study consist dose escalation phase determine maximum tolerate dose ( MTD ) OTD follow separate cohort expansion phase OTD administer .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Newborn</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Adult</mesh_term>
	<mesh_term>Acute Lung Injury</mesh_term>
	<mesh_term>Lung Injury</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Interferon-beta</mesh_term>
	<criteria>Adult male female patient ALI/ARDS confirm combination follow diagnostic criterion : An initiate clinical condition ( e.g . sepsis , pneumonia , aspiration pneumonia , pancreatitis etc . ) Acute onset Bilateral infiltrates document chest radiograph endaspiratory position The absence clinical evidence leave atrial hypertension ALI : partial pressure oxygen ( PaO2 ) / fraction inspire oxygen ( FiO2 ) ratio ≤300 mmHg stable state patient adapt standardised ventilation . ( Within UK equate &lt; 40kPa ) ARDS : PaO2 /FiO2 ≤200 mmHg stable state patient adapt standardised ventilation . ( Within UK equate &lt; 26.7kPa ) Provision sign write informed consent patient patient legally authorize representative . Age great equal 18 . Initiation study drug within 48 hour diagnosis ALI/ARDS . All patient entry require receive mechanical ventilatory support . Only patient consider suitable active life support enrol study . No clinical evidence leave atrial hypertension would explain pulmonary infiltrates ; measure pulmonary arterial wedge pressure less equal 18mmHg Patients burn . Women know pregnant , lactate positive indeterminate pregnancy test . Patients significant Chronic Obstructive Pulmonary Disease require ongoing treatment e.g . chronic use oxygen ventilatory support home prior admission . Patients primary lung cancer presence secondary metastasis lung . Patients require treatment congestive heart failure . Patients receive renal dialysis therapy chronic renal failure . Patients take immunomodulatory therapy oral steroid admission . Prior use interferon . Inability maintain blood pressure ensure adequate end organ perfusion . It note use plasma colloid vasopressor agent allow achieve maintenance blood pressure . Current participation another experimental treatment protocol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Open label</keyword>
</DOC>